Literature DB >> 22388279

No evidence for the reversal of adrenal failure after hematopoietic cell transplantation in X-linked adrenoleukodystrophy.

A Petryk, L E Polgreen, S Chahla, W Miller, P J Orchard.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22388279      PMCID： PMC4547590          DOI： 10.1038/bmt.2012.33

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

1.  Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison's disease improves survival and neurological outcomes.

Authors:  Lynda E Polgreen; Saydi Chahla; Weston Miller; Steven Rothman; Jakub Tolar; Teresa Kivisto; David Nascene; Paul J Orchard; Anna Petryk
Journal:  Eur J Pediatr       Date:  2011-01-29       Impact factor: 3.183

Review 2.  X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects.

Authors:  Johannes Berger; Jutta Gärtner
Journal:  Biochim Biophys Acta       Date:  2006-07-26

3.  Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice.

Authors:  Marija Djukic; Alexander Mildner; Hauke Schmidt; Dirk Czesnik; Wolfgang Brück; Josef Priller; Roland Nau; Marco Prinz
Journal:  Brain       Date:  2006-08-03       Impact factor: 13.501

4.  Variability of endocrinological dysfunction in 55 patients with X-linked adrenoleucodystrophy: clinical, laboratory and genetic findings.

Authors:  G C Korenke; C Roth; E Krasemann; M Hüfner; D H Hunneman; F Hanefeld
Journal:  Eur J Endocrinol       Date:  1997-07       Impact factor: 6.664

5.  Adreno-leukodystrophy: oxidative stress of mice and men.

Authors:  James M Powers; Zhengtong Pei; Ann K Heinzer; Rebecca Deering; Ann B Moser; Hugo W Moser; Paul A Watkins; Kirby D Smith
Journal:  J Neuropathol Exp Neurol       Date:  2005-12       Impact factor: 3.685

6.  Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999.

Authors:  Charles Peters; Lawrence R Charnas; Ye Tan; Richard S Ziegler; Elsa G Shapiro; Todd DeFor; Satkiran S Grewal; Paul J Orchard; Susan L Abel; Anne I Goldman; Norma K C Ramsay; Kathryn E Dusenbery; Daniel J Loes; Lawrence A Lockman; Shunichi Kato; Patrick R Aubourg; Hugo W Moser; William Krivit
Journal:  Blood       Date:  2004-04-08       Impact factor: 22.113

7.  Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters.

Authors:  J Mosser; A M Douar; C O Sarde; P Kioschis; R Feil; H Moser; A M Poustka; J L Mandel; P Aubourg
Journal:  Nature       Date:  1993-02-25       Impact factor: 49.962

8.  Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro.

Authors:  R W Whitcomb; W M Linehan; R A Knazek
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808
  8 in total
  4 in total

Review 1.  Pathophysiology of X-linked adrenoleukodystrophy.

Authors:  J Berger; S Forss-Petter; F S Eichler
Journal:  Biochimie       Date:  2013-12-04       Impact factor: 4.079

Review 2.  ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy.

Authors:  Alyssa M Volmrich; Lauren M Cuénant; Irman Forghani; Sharon L Hsieh; Lauren T Shapiro
Journal:  Appl Clin Genet       Date:  2022-08-12

3.  Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme.

Authors:  Alice Bessey; James B Chilcott; Joanna Leaviss; Anthea Sutton
Journal:  Orphanet J Rare Dis       Date:  2018-10-11       Impact factor: 4.123

Review 4.  Monitoring for and Management of Endocrine Dysfunction in Adrenoleukodystrophy.

Authors:  Isha Kachwala; Molly O Regelmann
Journal:  Int J Neonatal Screen       Date:  2022-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.